image
Supernus Pharmaceuticals, Inc. SUPN
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 35.57
-1.69 %
$ 1.96 B
Market Cap
33.24
P/E
BALANCE SHEET
1.28 B ASSETS
-24.95%
Growth Rates
1Year -24.95%
3Years -5.29%
5Years 5.50%
7Years 22.45%
10Years 27.68%
356 M LIABILITIES
-56.37%
Growth Rates
1Year -56.37%
3Years -22.30%
5Years -7.46%
7Years 17.12%
10Years 16.47%
922 M EQUITY
3.98%
Growth Rates
1Year 3.98%
3Years 7.35%
5Years 15.26%
7Years 25.14%
10Years 39.31%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Supernus Pharmaceuticals, Inc.
image
Current Assets 493 M
Cash & Short-Term Investments 255 M
Receivables 144 M
Other Current Assets 94.1 M
Non-Current Assets 785 M
Long-Term Investments 16.6 M
PP&E 42.5 M
Other Non-Current Assets 725 M
Current Liabilities 290 M
Accounts Payable 1.96 M
Short-Term Debt 8.33 M
Other Current Liabilities 280 M
Non-Current Liabilities 66 M
Long-Term Debt 33.2 M
Other Non-Current Liabilities 32.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
ASSETS
Cash & Cash Equivalents 75.1 93.1 203.4 288.6 181.4 192.2 100.3 90.1 62.2 74.3 82.2 88.5 48.5 23.7 31.4 52.9
Short Term Investments 179.8 368.2 136.2 133.9 165.7 163.8 39.7 23.7 28.0 37.9 49.2 48.2 0 9.0 35.1 7.5
Receivables 144.2 165.5 148.9 140.9 87.3 102.9 65.6 41.5 25.9 17.3 5.1 0.7 0 0.2 3.7 2.3
Inventory 77.4 91.5 86.0 48.3 26.6 25.7 16.3 16.8 12.6 13.4 7.2 1.2 0.4 6.8 2.3 6.5
Other Current Assets 16.7 15.8 54.0 37.4 23.2 17.8 13.0 5.9 5.3 7.5 2.8 1.1 0.5 7.0 0.3 0.3
Total Current Assets 493.1 734.2 601.6 630.4 472.6 493.5 228.5 151.4 106.0 108.9 97.2 91.7 49.4 39.8 72.9 69.5
PP&E 42.5 15.2 17.0 37.8 38.3 4.1 5.1 4.3 3.9 2.4 2.6 1.4 1.3 1.2 1.9 2.0
Intangible Assets 599.9 702.5 784.7 442.3 24.8 31.4 36.0 16.5 1.0 5.4 1.2 0.7 0.9 1.1 1.4 1.6
Goodwill 117.0 117.0 117.5 77.9 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 16.6 93.9 119.2 350.4 591.8 418.8 133.6 75.4 55.0 19.8 8.8 0 0 0 0 0
Other Long Term Assets 8.5 (10.0) (36.1) 8.0 0.6 0.4 0.4 20.2 0.4 6.4 1.5 0.1 2.1 4.8 3.8 4.1
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 277.7 1 702.5 1 689.2 1 504.1 1 160.3 977.8 424.5 309.6 188.7 137.5 111.0 94.0 53.7 47.0 79.9 77.1
LIABILITIES
Accounts Payable 2.0 10.5 9.3 6.1 10.1 3.2 6.8 8.1 4.3 1.9 3.1 2.8 10.1 11.3 6.2 4.5
Short Term Debt 8.3 408.8 13.7 12.8 6.1 2.2 4.3 0 (17.1) 0 0 11.8 8.2 0 0 0
Other Current Liabilities 279.9 268.7 292.3 226.1 141.9 143.6 95.6 72.5 51.9 25.5 15.2 7.9 1.7 3.9 3.8 3.8
Total Current Liabilities 290.2 688.0 315.4 245.1 160.6 161.4 123.0 80.7 56.1 27.5 26.4 23.0 18.8 15.2 10.0 8.3
Long Term Debt 33.2 36.0 420.6 424.0 375.6 329.5 22.3 4.2 7.1 26.9 34.4 11.1 21.8 75.0 75.0 75.0
Deferred Tax Income 25.0 49.8 85.4 35.2 37.3 31.5 15.0 0.1 0.9 6.6 12.6 (0.3) 0.9 0 0 (75.0)
Other Liabilities 7.8 42.5 52.0 90.2 28.7 34.0 10.6 31.4 35.2 10.4 15.3 2.0 1.4 1.1 1.0 0.2
Total Liabilities 356.2 816.3 873.3 759.2 564.9 524.8 157.0 117.8 69.9 66.2 77.5 36.4 44.3 91.3 86.1 83.9
EQUITY
Common Stock 55 K 54 K 53 K 53 K 53 K 52 K 51 K 50 K 49 K 43 K 40 K 31 K 14 K 2 K 6 K 5.52 K
Retained Earnings 482.6 481.2 379.9 326.5 199.5 86.5 (26.8) (84.3) (144.6) (158.7) (178.5) (86.3) (40.0) (93.8) (55.3) (55.8)
Other Accumulative Comprehensive Income/Loss (0.6) (3.2) 1.5 9.0 7.4 (3.2) (0.7) (0.1) (0.5) (0.2) 0 57 K 1 K 0 2 K (2.1)
Total Equity 921.5 886.2 815.9 744.9 595.4 453.0 267.5 191.8 118.9 71.4 33.5 57.6 9.4 (44.3) (6.2) (6.7)
Total Liabilities and Equity 1 277.7 1 702.5 1 689.2 1 504.1 1 160.3 977.8 424.5 309.6 188.7 137.5 111.0 94.0 53.7 47.0 79.9 77.1
SHARES OUTSTANDING
Common Shares Outstanding 54.5 53.7 53.1 52.6 52.4 52.0 50.8 49.5 47.5 42.3 31.8 17.4 13.9 13.9 13.9 13.9 13.9